Last year this Advanced Pharmaceutical small-cap company share traded at a price of ₹140 & now it is trading at ₹4000 which is more than 30x return in 1 year.
Remedium Lifecare Ltd a smallcap company in the business of trading in Advanced Pharmaceutical Intermediates and other pharma products announced a 9:5 bonus issue.
Remedium Lifecare Bonus details
| Company Name | Ex Date | Purpose | Record Date |
|---|---|---|---|
| Remedium Lifecare Ltd | 28 Jul 2023 | Bonus issue 9:5 | 29 Jul 2023 |
Business Overview:
Company does trading and sale of API intermediates (KSMs & CRMs) and various other raw materials used in API trading to innovator and generic pharmaceutical players in Domestic and International markets
Product Profile:
a) Active Pharmaceutical Ingredients: Lipid Lowering Agent, Antidepressant, Anti-Asthmatic, Anti-Histamine, Proton Pump Inhibitor, Active mucolytic agent, Anti-Hypertension, Decongestant, Anti-emetic, Anti-convulsant
b) CRMs and advanced intermediates: Tartaric Acid Salt, ThiopheneTosylate, Couple Amine Hydrochloride, Pantoprazole Sulphide, Chloro Compound, Cetirizine Base, Levo CBP
Revenue Breakup:
In FY22, company generated its entire revenue from Sale of Products
Quarterly Results
Figures in Rs. Crores
| Mar 2022 | Dec 2022 | Mar 2023 | |
|---|---|---|---|
| Sales + | 40.29 | 176.48 | 75.58 |
| Expenses + | 40.88 | 174.95 | 78.48 |
| Operating Profit | -0.59 | 1.53 | -2.90 |
| OPM % | -1.46% | 0.87% | -3.84% |
| Other Income + | 0.00 | 0.02 | 0.00 |
| Interest | 0.11 | 0.02 | -0.10 |
| Depreciation | 0.02 | 0.01 | 0.01 |
| Profit before tax | -0.72 | 1.52 | -2.81 |
| Tax % | -62.50% | 0.00% | -70.11% |
| Net Profit + | -1.16 | 1.52 | -4.78 |
| EPS in Rs | -3.22 | 4.22 | -13.28 |
Merger:
On 14th November 2022, company approved Memorandum of Understanding for proposed merger of MVK Lifesciences Private Limited into company for strategic reasons.